Altius Minerals Corporation (0UHC)
London Exchange · UK · prices in CAD · close of 21 Oct 2026
Key indicators
| Last close | CAD 55.53 |
|---|---|
| 52-week range | 26.51 – 69.29 |
| Return, 1 month / 3 months | −17.9% / −2.0% |
| Return, 1 year / 3 years | +109.9% / – |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 30 |
| Volatility (1 year) | 46.1% |
| Worst drawdown (1 year) | -20.2% |
| Average daily value traded | 0.02M CAD |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Altius Minerals Corporation is a royalty company based in Canada that holds interests in mining and resource projects. It earns revenue from royalties on production of commodities such as potash, copper, iron ore and other metals, and it also holds equity stakes in resource companies. Its partners and counterparties are mining operators, and it has extended its royalty model into renewable energy projects. The company focuses on acquiring long-life royalty assets rather than operating mines itself.
On this site Altius Minerals Corporation appears as a stock on the London Exchange (UK), code 0UHC, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Altius Minerals Corporation (0UHC) trades on the London Exchange in UK. It last closed at CAD 55.53 on 21 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 1,972 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 109.9% and over the last three months it fell 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.4% | ||
| From 52-week high | -19.4% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.0% | ||
| 6-month return | 7.7% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 46.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.2% | ||
| Liquidity | 17 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −7.6% |
|---|---|
| 1 month | −17.9% |
| 3 months | −2.0% |
| 6 months | +7.7% |
| 1 year | +109.9% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 63.95 / 54.22 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.06 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | CAD 0.1100 |
| 29 May 2026 | CAD 0.1000 |
| 19 Mar 2026 | CAD 0.1000 |
| 28 Nov 2025 | CAD 0.1000 |
| 29 Aug 2025 | CAD 0.1000 |
| 30 May 2025 | CAD 0.0900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.